1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream — Uses, Side Effects, Dosage

1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream

Prescription

商品名： PROCORT

剤形

Topical

投与経路

TOPICAL

製造会社

WOMENS CHOICE PHARMACEUTICALS LLC

About This Medication

DESCRIPTION: ProCort® is a topical preparation containing hydrocortisone acetate 1.85% and pramoxine hydrochloride 1.15% in a hydrophilic and hydrophobic cream base which contains patented *Invisicare M1 polymer technology. Active Ingredients: Hydrocortisone Acetate 1.85%, Pramoxine HCL 1.15% Inactive Ingredients: Polysorbate-60, Poloxamer 124, PVM/MA copolymer VP/Hexadecene copolymer VP/Eicosene copolymer, Tocopheryl acetate, Aminomethyl propanediol, Stearic Acid, Phenoxyethanol, and Sterilized Water. Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below. formula

有効成分

成分	含有量
Hydrocortisone Acetate	-
Pramoxine Hydrochloride	-

適応症と用法

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

用量と投与方法

topical corticosteroids are generally applied to the affected area as a thin film 3 to 4 times daily, depending on the severity of the condition. Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted. Directions for rectal administration: 1. To open, remove foil, tab or puncture foil seal with cap. 2. Remove the applicator’s wrapping and attach the applicator to the tube. 3. Squeeze the tube to fill the applicator and lubricate the tip with cream. 4. Gently insert the applicator into rectum and squeeze tube begin to force the required amount of cream into rectum. 5. Wipe applicator tip clean remove and discard. 6. Securely apply screw cap on tube.

Side Effects Overview

The following local adverse reactions are reported in frequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence; itching, burning, skin irritation.

禁忌

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Frequently Asked Questions

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

topical corticosteroids are generally applied to the affected area as a thin film 3 to 4 times daily, depending on the severity of the condition. Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted. Directions for rectal administration: 1. To open, remove foil, tab or puncture foil seal with cap. 2. Remove the applicator’s wrapping and attach the applicator …

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

References & Data Sources

• DailyMed — 1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream drug label (National Library of Medicine)
• openFDA — 1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream label data (U.S. Food & Drug Administration)
• RxNorm — RXCUI 1114854 (NLM Normalized Drug Names)
• NDC Directory — 1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream (FDA National Drug Code)

医療免責事項

このページの情報は教育目的のみを意図しており、専門家による医療アドバイス、診断、または治療の代替として使用すべきではありません。

疾患や医薬品に関するご質問がある場合は、必ず担当医またはその他の資格を持つ医療専門家にご相談ください。

データソース： DailyMed (NLM), openFDA, MFDS